Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02509546
What this trial is testing

8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00750815
What this trial is testing

Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 58
Early research (Phase 1)Looking for participantsNCT05963217
What this trial is testing

Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

Who this might be right for
Relapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma
University Health Network, Toronto 19
Testing effectiveness (Phase 2)Study completedNCT00607997
What this trial is testing

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Who this might be right for
LeukemiaAcute DiseaseAcute Myeloid Leukemia+2 more
Sunesis Pharmaceuticals 113
Early research (Phase 1)Study completedNCT00641589
What this trial is testing

Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Post-approval studies (Phase 4)Not Yet RecruitingNCT07162090
What this trial is testing

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

Who this might be right for
SarcopeniaAnemia Associated With Chronic Kidney Disease (CKD)Dialysis Patients
Tianjin Medical University General Hospital 60
Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Large-scale testing (Phase 3)Ended earlyNCT01425307
What this trial is testing

Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea

Who this might be right for
Sickle Cell Anemia
Children's Hospital Medical Center, Cincinnati 159
Large-scale testing (Phase 3)WithdrawnNCT00269971
What this trial is testing

Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.

Who this might be right for
AnemiaBlood TransfusionOrthopedic Surgery
Janssen-Ortho Inc., Canada
Early research (Phase 1)Looking for participantsNCT07025564
What this trial is testing

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Early research (Phase 1)Active Not RecruitingNCT03773393
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)

Who this might be right for
Bone Marrow Disease
Cellenkos, Inc. 18
Not applicableStudy completedNCT00004875
What this trial is testing

Heparin or Enoxaparin in Patients With Cancer

Who this might be right for
LymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 6
Large-scale testing (Phase 3)WithdrawnNCT00226512
What this trial is testing

To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Hadassah Medical Organization 203
Not applicableStudy completedNCT01974271
What this trial is testing

An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)

Who this might be right for
Anemia
Hoffmann-La Roche 661
Testing effectiveness (Phase 2)Study completedNCT01109264
What this trial is testing

Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Jiangsu Simcere Pharmaceutical Co., Ltd. 147
Not applicableStudy completedNCT06659224
What this trial is testing

The Risk of Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma

Who this might be right for
Acute Myeloid Leukemia (AML)Ewing Sarcoma
asmaa salama ibrahim 2,631
Testing effectiveness (Phase 2)Study completedNCT01151423
What this trial is testing

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 75
Testing effectiveness (Phase 2)Ended earlyNCT01646762
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Mayo Clinic 13
Not applicableStudy completedNCT04812873
What this trial is testing

Registry Study of ID & IDA in Korean Patients With Heart Failure

Who this might be right for
Iron Deficiency Anemia
JW Pharmaceutical 465
Next Page